Subscribe
scientist-istock-505918900
gevende / iStockphoto.com
19 September 2018Big Pharma

Cancer Research UK invests £14m in biotherapeutics hub

Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million ($18.4 million) investment from charity Cancer Research UK.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Cancer Research UK forms immunotherapy alliance
28 March 2019   Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.
Big Pharma
Cancer Research UK partners with VC firm in $25m deal
3 July 2019   Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Biotechnology
Cancer Research UK forms immunotherapy alliance
28 March 2019   Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.
Big Pharma
Cancer Research UK partners with VC firm in $25m deal
3 July 2019   Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

More on this story

Biotechnology
Cancer Research UK forms immunotherapy alliance
28 March 2019   Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.
Big Pharma
Cancer Research UK partners with VC firm in $25m deal
3 July 2019   Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug